Главная страница
russian   english
16+
<< назад

Название статьи

СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ ГЕПАТИТА С: УСПЕХИ В ИЗУЧЕНИИ И НЕРЕШЕННЫЕ ВОПРОСЫ


Номер журнала
2
Дата выпуска
2012

Тип статьи
научная статья
Коды УДК
616.36-002.14:616.988
Страницы
45-49
Ключевые слова
гепатит С, скрытая гепатит С-инфекция, неопределенные результаты

Авторы
Евплова Ирина Алексеевна

Место работы
Евплова Ирина Алексеевна
Нижегородский НИИ эпидемиологии и микробиологии им. И.Н. Блохиной


Аннотация
В обзоре приведены современные данные литературы, касающиеся эпидемиологических, вирусологических и иммунологических аспектов проблемы гепатита С. Особое внимание уделено рассмотрению публикаций, посвященных изучению скрытой гепатит С-инфекции.

Загрузить статью

Библиографический список
1 . Chen S.L., Morgan T.R. The natural history of hepatitis C virus (HCV) infection // Int. J. Med. Sci. 2006. V. 3. № 2. P. 47–52.
2 . WHO. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium // J. Viral Hepat. 1999. V. 6. P. 35–47.
3 . Sy T., Jamal M.M. Epidemiology of hepatitis C- virus (HCV) infection // Int. J. Med. Sci. 2006. V. 3. № 2. P. 41–46.
4 . Alter M J. Epidemiology of hepatitis C virus infection // World J. Gastroenterol. 2007. V. 13. № 17. P. 2436–2441.
5 . Esteban J.I., Sauleda S., Quer J. The changing epidemiology of hepatitis C virus infection in Europe // J. Hepatol. 2008. V. 48. № 1. P. 148–162.
6 . Choo Q.L., Kuo G., Weiner A.J. et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome // Science. 1989. V. 244. P. 359–362.
7 . Wasley A., Alter M.J. Epidemiology of hepatitis C: geographic differences and temporal trends // Semin Liver Dis. 2000. V. 20. № 1. P. 1–16.
8 . M?hlberger N., Schwarzer R., Lettmeier B. et al. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality // BMC Public Health. 2009. V. 9. P. 34.
9 . Ершова О.Н. Современные проявления эпидемического процесса гепатита С, активность естественных путей передачи и совершенствование профилактики этой инфекции. Автореферат дис. … д-ра мед. наук. М., 2006. 47 с.
10 . Brass V., Moradpour D., Blum H.E. Molecular virology of hepatitis C virus (HCV): 2006 Update // Int. J. Med. Sci. 2006. V. 3. № 2. P. 29–34.
11 . Penin F., Dubuisson J., Rey F.A. et al. Structural biology of hepatitis C virus // Hepatology. 2004. V. 39. № 1. P. 5–19.
12 . Sharma S.D. Hepatitis C virus: molecular biology and current therapeutic options // Indian J. Med. Res. 2010. V. 131. P. 17–34.
13 . Crovatto M., Pozzato G., Zorat F. et al. Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites of the virus // Haematologica. 2000. V. 85. № 4. P. 356–361.
14 . Pham T.N., King D., Macparland S.A. et al. Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection // Gastroenterology. 2008. V. 134. № 3. P. 812–822.
15 . Вишневская Т.В., Масалова О.В., Альховский С.В. и др. Выявление маркеров репликации вируса гепатита С в мононуклеарных клетках периферической крови больных хроническим гепатитом С // Медицинская иммунология. 2008. Т. 10. № 4–5. С. 397–404.
16 . Мальков П.Г., Данилова Н.В., Москвина Л.В. Внепеченочные осложнения хронического вирусного гепатита С (обзор) // Фундаментальные исследования. 2008. № 11. С. 22–27.
17 . Kanto T., Hayashi N. Innate immunity in hepatitis C virus infection: Interplay among dendritic cells, natural killer cells and natural killer T cells // Hepatol. Res. 2007. V. 37. P. 319–326.
18 . Saito T., Gale M.Jr. Regulation of innate immunity against hepatitis C virus infection // Hepatol. Res. 2008. V. 38. № 2. P. 115–122.
19 . Semmo N., Klenerman P. CD4+ T cell responses in hepatitis C virus infection // World J. Gastroenterol. 2007. V. 13. № 36. P. 4831–4838.
20 . Krishnadas D.K., Li W., Kumar R., Tyrrell L.J., Agrawal B. In vitro activation and differentiation of na?ve CD4+ and CD8+ T cells into HCV core- and NS3- specific armed effector cells: a new role for CD4+ T cells // Cell Immunol. 2009. V. 259. № 2. P. 141–149.
21 . Frebel H., Richter K., Oxenius A. How chronic viral infections impact on antigen-specific T-cell responses // Eur. J. Immunol. 2010. V. 40. № 3. P. 654–663.
22 . Kanto T., Hayashi N. Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptive immunity // Intern. Med. 2006. V. 45. № 4. P. 183–191.
23 . Thimme R., Oldach D., Chang K.-M. Determinants of viral clearance and persistence during acute hepatitis C virus infection // J. Exp. Med. 2001. V. 194. № 10. P. 1395–1406.
24 . Logvinoff C., Major M.E., Oldach D. et al. Neutralizing antibody response during acute and chronic hepatitis C virus infection // Proc. Natl. Acad. Sci. USA. 2004. V. 10. № 27. P. 10149–10154.
25 . Rehermann B. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence // J. Clin. Invest. 2009. V. 119. № 7. P. 1745–1754.
26 . Новиков В.В. Растворимые формы мембранных белков клеток иммунной системы при вирусных инфекциях // Вестник Нижегородского ун-та им. Н.И. Лобачевского. С. Биология. 2001. C. 208–217.
27 . Castillo I., Pardo M., Bartolom? J. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown // J. Infect. Dis. 2004. V. 189. P. 7–14.
28 . Radkowski M., Horban A., Gallegos-Orozco J.F. et al. Evidence for viral persistence in patients who test positive for anti–hepatitis C virus antibodies and have normal alanine aminotransferase levels // J. Infect. Dis. 2005. V. 191. P. 1730–1733.
29 . Castillo I., Rodr?guez-I?igo E., L?pez-Alcorocho J.M. et al. Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment // Clinical Infectious Diseases. 2006. V. 43. P. 1277–1283.
30 . Carre?o V., Bartolom? J., Castillo I., Quiroga J.A. Occult hepatitis B virus and hepatitis C virus infections // Rev. Med. Virol. 2008. V. 18. № 3. P. 139–157.
31 . Pham T.N.Q., Coffin C.S., Michalak T. Occult hepatitis C virus infection: what does it mean? // Liver International. 2010. V. 30. № 4. P. 502–511.
32 . Carre?o V. Occult hepatitis C virus infection: A new form of hepatitis C // World J. Gastroenterol 2006. V. 12. № 43. P. 6922–6925.
33 . Hoare M., Gelson W.T., Rushbrook S.M. et al. Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection // Hepatology. 2008. V. 48. № 6. P. 1737–1745.
34 . Pham T.N., King D., Macparland S.A. et al. Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection // Gastroenterology. 2008. V. 134. № 3. P. 812–822. 1. 1. Pham T.N.Q., Michalak T.I. Occult persistence and lymphotropism of hepatitis C virus infection // World J. Gastroenterol. 2008. V. 14. № 18. P. 2789–2793.
35 . Quiroga J.A., Llorente S., Castillo I., Rodr?guez-I?igo E., Pardo M., Carre?o V. Cellular immune responses associated with occult hepatitis C virus infection of the liver // J. Virol. 2006. V. 80. № 22. P. 10972–10979.
36 . Pham T.N., Mercer S.E., Michalak T.I. Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles // J. Viral. Hepat. 2009. V. 16. № 8. P. 547–56.
37 . Kiely P., Kay D., Parker S., Piscitelli L. The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays // Transfusion. 2004. V. 44. № 3. P. 349–358.
38 . Piro L., Solinas S., Luciani M. Prospective study of the meaning of indeterminate results of the Recombinant Immunoblot Assay for hepatitis C virus in blood donors // Blood Transfus. 2008. V. 6. № 2. P. 107–111.
39 . Melve G.K., Myrmel H., Eide G.E., Hervig T. Evaluation of the persistence and characteristics of indeterminate reactivity against hepatitis C virus in blood donors // Transfusion. 2009. V. 49. № 11. P. 2359–2365.
40 . R?os M., Diago M., Rivera P. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus // J. Viral. Hepat. 2006. V. 13. № 3. P. 177–181.
41 . Torres K.L., Malheiro A., Tateno A. et al. Hepatitis C virus in blood donors, Brazil // Emerg. Infect. Dis. 2009. V. 15. № 4. P. 676–678.
42 . Widell A., Busch M. Exposed or not exposed – that is the question: evidence for resolving and abortive hepatitis C virus infections in blood donors // Transfusion. 2009. V. 49. № 7. P. 1277–1281.
43 . Semmo N., Barnes E., Taylor C. T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors // Lancet. 2005. V. 365. № 9456. P. 327–329.
44 . Hitziger T., Schmidt M., Schottstedt V. et al. Cellular immune response to hepatitis C virus (HCV) in nonviremic blood donors with indeterminate anti-HCV reactivity // Transfusion. 2009.V. 49. № 7. P. 1306–1313.